Cargando…
COVID-19 vaccine effectiveness in preventing deaths among high-risk groups in Tamil Nadu, India
Autores principales: | Jaiswal, Anoop, Subbaraj, V., Vivian Thangaraj, Jeromie Wesley, Murhekar, Manoj V., Muliyil, Jayaprakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555612/ https://www.ncbi.nlm.nih.gov/pubmed/34213434 http://dx.doi.org/10.4103/ijmr.ijmr_1671_21 |
Ejemplares similares
-
Clinical profile of patients infected with suspected SARS-CoV-2 Omicron variant of concern, Tamil Nadu, India, December 2021-January 2022
por: Raju, Mohan Kumar, et al.
Publicado: (2022) -
Japanese encephalitis in Tamil Nadu (2007-2009)
por: Gunasekaran, P., et al.
Publicado: (2012) -
Management of gastrointestinal services in Tamil Nadu, India, during COVID-19
por: Ramakrishnan, Arulraj, et al.
Publicado: (2021) -
Intussusception hospitalizations before rotavirus vaccine introduction: Retrospective data from two referral hospitals in Tamil Nadu, India
por: Srinivasan, Rajan, et al.
Publicado: (2018) -
Coverage of childhood vaccination among children aged 12-23 months, Tamil Nadu, 2015, India
por: Murhekar, Manoj V., et al.
Publicado: (2017)